Jagsonpal Pharma

{
  "main_header": {
    "sid": 134241,
    "name": "Jagsonpal Pharma",
    "stock_name": "Jagsonpal Pharma",
    "full_name": "Jagsonpal Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/jagsonpal-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "217.90",
    "chg": 4.55,
    "chgp": "2.13%",
    "dir": 1,
    "prev_price": "213.35",
    "mcapval": "1,467.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 507789,
    "symbol": "JAGSNPHARM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE048B01035",
    "curr_date": "May 08",
    "curr_time": "",
    "bse_nse_vol": "2.64 lacs",
    "exc_status": "Active",
    "traded_date": "May 08, 2026",
    "traded_date_str": "2026 05 08",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/jagsonpal-pharma-134241-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Jagsonpal Pharmaceuticals Ltd Upgraded to Sell on Technical Improvements Despite Financial Challenges",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jagsonpal-pharmaceuticals-ltd-upgraded-to-sell-on-technical-improvements-despite-financial-challenges-3980835",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/JagsonpalPharma_mojoScore_3980835.png",
        "date": "2026-05-08 08:05:00",
        "description": "Jagsonpal Pharmaceuticals Ltd has seen its investment rating upgraded from Strong Sell to Sell, driven primarily by a shift in technical indicators despite ongoing financial headwinds. The company’s quality, valuation, financial trend, and technical parameters have been reassessed, reflecting a nuanced outlook for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Jagsonpal Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jagsonpal-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3980590",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/JagsonpalPharma_technicaldot_3980590.png",
        "date": "2026-05-08 08:00:16",
        "description": "Jagsonpal Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Despite a modest day gain of 1.84%, the stock’s technical indicators present a complex picture, with mixed signals across weekly and monthly timeframes, reflecting uncertainty in near-term price direction."
      },
      {
        "title": "Jagsonpal Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jagsonpal-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3974561",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/JagsonpalPharma_technicaldot_3974561.png",
        "date": "2026-05-05 08:00:16",
        "description": "Jagsonpal Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a modest day gain of 0.93%, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, Bollinger Bands, and moving averages, reflecting cautious investor sentiment in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Jagsonpal Pharmaceuticals Gains 5.44%: Mixed Technical Signals Shape Weekly Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jagsonpal-pharmaceuticals-gains-544-mixed-technical-signals-shape-weekly-momentum-3971958",
        "imagepath": "",
        "date": "2026-05-03 16:00:04",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>27 Apr:</strong> Stock opens strong at Rs.203.95 (+2.26%) amid positive market sentiment</p>\n                    <p><strong>28 Apr:</strong> Q4 FY26 results reveal profit surge; technical momentum shifts amid mixed indicators</p>\n                    <p><strong>29 Apr:</strong> Technical momentum moves to sideways trend with continued gains (+1.19%)</p>\n                    <p><strong>30 Apr:</strong> Week closes at Rs.210.30, up 5.44% for the week, outperforming Sensex</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.199.45</div></div>\n                    ..."
      },
      {
        "title": "Jagsonpal Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jagsonpal-pharmaceuticals-ltd-is-rated-strong-sell-3972949",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/JagsonpalPharma_mojoScore_3972949.png",
        "date": "2026-05-03 10:10:13",
        "description": "Jagsonpal Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 27 Apr 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 03 May 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Jagsonpal Pharmaceuticals Ltd: Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jagsonpal-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3967335",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/JagsonpalPharma_technicaldot_3967335.png",
        "date": "2026-04-29 08:00:12",
        "description": "Jagsonpal Pharmaceuticals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, is currently exhibiting a complex technical profile with a shift from mildly bearish to sideways momentum. Despite a modest day gain of 1.20%, the stock’s technical indicators present a nuanced picture, reflecting both bullish and bearish signals across weekly and monthly timeframes."
      },
      {
        "title": "Are Jagsonpal Pharmaceuticals Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-jagsonpal-pharmaceuticals-ltd-latest-results-good-or-bad-3967118",
        "imagepath": "",
        "date": "2026-04-28 19:13:41",
        "description": "Jagsonpal Pharmaceuticals Ltd's latest financial results for Q4 FY26 present a mixed picture. The company reported a net profit of ₹8.76 crores, reflecting a year-on-year growth of 33.13%. However, this represents a sequential decline of 20.00% compared to the previous quarter. Similarly, revenue for the quarter was ₹64.20 crores, which is a 9.63% increase year-on-year but shows a significant sequential contraction of 11.99% from ₹72.95 crores in Q3 FY26. \n\nThe operating margin, excluding other income, was recorded at 17.38%, which is an improvement of 248 basis points year-on-year but a notable decrease of 494 basis points from the previous quarter's margin of 22.32%. This decline in margins raises concerns about the company's operational efficiency and cost management in the face of revenue pressures.\n\nOverall, while Jagsonpal Pharmaceuticals has demonstrated resilience in year-on-year comparisons, the se..."
      },
      {
        "title": "Jagsonpal Pharmaceuticals Q4 FY26: Profit Surge Masks Sequential Weakness",
        "link": "https://www.marketsmojo.com/news/result-analysis/jagsonpal-pharmaceuticals-q4-fy26-profit-surge-masks-sequential-weakness-3966600",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/JagsonpalPharma_quaterlyResult_3966600.png",
        "date": "2026-04-28 09:45:47",
        "description": "Jagsonpal Pharmaceuticals Ltd., a micro-cap pharmaceutical manufacturer with a market capitalisation of ₹1,359.00 crores, reported net profit of ₹8.76 crores for Q4 FY26, marking a robust 33.13% year-on-year growth from ₹6.58 crores in Q4 FY25. However, the quarter revealed concerning sequential trends as profits declined 20.00% from ₹10.95 crores in Q3 FY26, whilst revenues contracted 11.99% quarter-on-quarter to ₹64.20 crores. The stock traded at ₹207.00 on April 28, 2026, up 1.50% from the previous close, though it remains 31.41% below its 52-week high of ₹301.80."
      },
      {
        "title": "Jagsonpal Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jagsonpal-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-indicators-3965311",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/JagsonpalPharma_technicaldot_3965311.png",
        "date": "2026-04-28 08:00:21",
        "description": "Jagsonpal Pharmaceuticals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, with recent indicators signalling a transition from sideways to mildly bearish trends. Despite a 2.26% gain on 28 Apr 2026, the stock’s technical parameters present a complex picture, reflecting both bullish and bearish signals across different timeframes."
      }
    ],
    "total": 250,
    "sid": "134241",
    "stock_news_url": "https://www.marketsmojo.com/news/jagsonpal-pharmaceuticals-134241"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "07-May-2026",
      "details": "Newspaper Publication regarding dispatch of Letter of Offer of Buy Back to the shareholders of the Company",
      "source": "BSE"
    },
    {
      "caption": "Submission Of Letter Of Offer For Buy-Back Upto 1600000 Equity Shares",
      "datetime": "06-May-2026",
      "details": "Submission of Letter of Offer for Buy- Back upto 1600000 Equity Shares at price of INR-250/- per share amounting to INR-400000000/-",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "04-May-2026",
      "details": "Earning Call Transcript for meeting held on April 28 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Jagsonpal Pharmaceuticals Ltd has declared <strong>125%</strong> dividend, ex-date: 12 Sep 25",
          "dt": "2025-09-12",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Jagsonpal Pharmaceuticals Ltd has announced <strong>2:5</strong> stock split, ex-date: 08 Jan 25",
          "dt": "2025-01-08",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Jagsonpal Pharmaceuticals Ltd Upgraded to Sell on Technical Improvements Despite Financial Challenges

2026-05-08 08:05:00

Jagsonpal Pharmaceuticals Ltd has seen its investment rating upgraded from Strong Sell to Sell, driven primarily by a shift in technical indicators despite ongoing financial headwinds. The company’s quality, valuation, financial trend, and technical parameters have been reassessed, reflecting a nuanced outlook for investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

Jagsonpal Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-05-08 08:00:16

Jagsonpal Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Despite a modest day gain of 1.84%, the stock’s technical indicators present a complex picture, with mixed signals across weekly and monthly timeframes, reflecting uncertainty in near-term price direction.

Read full news article

Jagsonpal Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-05-05 08:00:16

Jagsonpal Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a modest day gain of 0.93%, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, Bollinger Bands, and moving averages, reflecting cautious investor sentiment in the Pharmaceuticals & Biotechnology sector.

Read full news article

Jagsonpal Pharmaceuticals Gains 5.44%: Mixed Technical Signals Shape Weekly Momentum

2026-05-03 16:00:04

Key Events This Week

27 Apr: Stock opens strong at Rs.203.95 (+2.26%) amid positive market sentiment

28 Apr: Q4 FY26 results reveal profit surge; technical momentum shifts amid mixed indicators

29 Apr: Technical momentum moves to sideways trend with continued gains (+1.19%)

30 Apr: Week closes at Rs.210.30, up 5.44% for the week, outperforming Sensex

Week Open

Rs.199.45

...

Read full news article

Jagsonpal Pharmaceuticals Ltd is Rated Strong Sell

2026-05-03 10:10:13

Jagsonpal Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 27 Apr 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 03 May 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Jagsonpal Pharmaceuticals Ltd: Technical Momentum Shifts Amid Mixed Indicator Signals

2026-04-29 08:00:12

Jagsonpal Pharmaceuticals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, is currently exhibiting a complex technical profile with a shift from mildly bearish to sideways momentum. Despite a modest day gain of 1.20%, the stock’s technical indicators present a nuanced picture, reflecting both bullish and bearish signals across weekly and monthly timeframes.

Read full news article

Are Jagsonpal Pharmaceuticals Ltd latest results good or bad?

2026-04-28 19:13:41

Jagsonpal Pharmaceuticals Ltd's latest financial results for Q4 FY26 present a mixed picture. The company reported a net profit of ₹8.76 crores, reflecting a year-on-year growth of 33.13%. However, this represents a sequential decline of 20.00% compared to the previous quarter. Similarly, revenue for the quarter was ₹64.20 crores, which is a 9.63% increase year-on-year but shows a significant sequential contraction of 11.99% from ₹72.95 crores in Q3 FY26. The operating margin, excluding other income, was recorded at 17.38%, which is an improvement of 248 basis points year-on-year but a notable decrease of 494 basis points from the previous quarter's margin of 22.32%. This decline in margins raises concerns about the company's operational efficiency and cost management in the face of revenue pressures. Overall, while Jagsonpal Pharmaceuticals has demonstrated resilience in year-on-year comparisons, the se...

Read full news article

Jagsonpal Pharmaceuticals Q4 FY26: Profit Surge Masks Sequential Weakness

2026-04-28 09:45:47

Jagsonpal Pharmaceuticals Ltd., a micro-cap pharmaceutical manufacturer with a market capitalisation of ₹1,359.00 crores, reported net profit of ₹8.76 crores for Q4 FY26, marking a robust 33.13% year-on-year growth from ₹6.58 crores in Q4 FY25. However, the quarter revealed concerning sequential trends as profits declined 20.00% from ₹10.95 crores in Q3 FY26, whilst revenues contracted 11.99% quarter-on-quarter to ₹64.20 crores. The stock traded at ₹207.00 on April 28, 2026, up 1.50% from the previous close, though it remains 31.41% below its 52-week high of ₹301.80.

Read full news article

Jagsonpal Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicators

2026-04-28 08:00:21

Jagsonpal Pharmaceuticals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, with recent indicators signalling a transition from sideways to mildly bearish trends. Despite a 2.26% gain on 28 Apr 2026, the stock’s technical parameters present a complex picture, reflecting both bullish and bearish signals across different timeframes.

Read full news article

View All News